关于先锋

Company Profile

The company has reached strategic cooperation with Duzheng Biotechnology


Release time:

2020-08-26

On August 24, Anhui Pioneer Pharmaceutical Co., Ltd. and Changsha Duzheng Biotechnology Co., Ltd. (referred to as "Duzheng Bio") formally signed a strategic cooperation agreement. Chen Zhenghao, Chairman of Pioneer Pharmaceuticals, Ouyang Dongsheng, Chairman/President of Duzheng Bio, Li Xiaohui, Vice President and other leaders attended the signing ceremony.

On August 24, Anhui Pioneer Pharmaceutical Co., Ltd. and Changsha Duzheng Biotechnology Co., Ltd. (referred to as "Duzheng Bio") formally signed a strategic cooperation agreement. Chen Zhenghao, Chairman of Pioneer Pharmaceuticals, Ouyang Dongsheng, Chairman/President of Duzheng Bio, Li Xiaohui, Vice President and other leaders attended the signing ceremony.

▲ Conference site

Pioneer Pharmaceuticals is a comprehensive modern medical and health enterprise engaged in high-level pharmaceutical research and development, production and promotion. Adhering to the concept of R&D-driven development, the company is committed to developing and producing high-quality products. At present, it has established a technological innovation system that combines production, learning, research and use with the enterprise as the main body.

At the meeting, Chen Zhenghao said that the best cooperation between enterprises is to enable both parties to develop together. Pioneer Pharmaceuticals is developing rapidly and has great prospects. Pioneer is full of confidence and expectations for the cooperation between the two parties. In the future, Duzheng Biotech will provide high-level technical services for Pioneer Pharmaceuticals, and the two parties will work together to help the industry develop.

▲ Ouyang Dongsheng, Chairman of Duzheng Biotechnology Co., Ltd.

▲Chen Zhenghao, Chairman of Pioneer Pharmaceuticals

Chen Zhenghao fully affirmed the development potential and technical level of Duzheng Biotechnology. He pointed out that this cooperation is based on a highly consistent strategic consensus between the two parties, and the advantages of the companies complement each other. In the future, we will jointly innovate the industry and create a new direction for development!

▲ Signing site

In the future, the two parties will carry out in-depth cooperation in clinical research, information system construction, platform and resource sharing, innovative technology and other fields, give full play to resource advantages, two-way empowerment, maximize value, and jointly promote the development of China's pharmaceutical industry!

Back →